Comparison of Coronary Vasodilation and Systemic Hemodynamic Effect of Two Doses of Intracoronary Sodium Nitroprusside for Coronary Fractional Flow Reserve

Special Article – Coronary Heart Disease

Austin Cardio & Cardiovasc Case Rep. 2017; 2(1): 1017.

Comparison of Coronary Vasodilation and Systemic Hemodynamic Effect of Two Doses of Intracoronary Sodium Nitroprusside for Coronary Fractional Flow Reserve

DePersis M¹*, Rudzinski W2,3, Singh M¹ and Kaluski E1,2*

1Division of Cardiology, Robert Packer Hospital, Guthrie Health Systems, Sayre PA, USA

2Rutgers New Jersey Medical School, Newark, NJ, USA

3East Orange Medical Center, East Orange, NJ, USA

*Corresponding author: Kaluski E, Director of Cardiac Catheterization Laboratories Guthrie Health Services and Robert Packer Hospital, Professor of Medicine Rutgers New Jersey Medical School, Professor of Medicine the Commonwealth Medical College (TCMC), USA

* DePersis M, Division of Cardiology, Robert Packer Hospital, Guthrie Health Systems, Sayre PA, USA

Received: July 07, 2017; Accepted: September 06, 2017; Published: September 13, 2017

Abstract

Background: Intracoronary bolus of 100 mcg of sodium nitroprusside (ICNTP) produces the same FFR response as intravenous infusion of adenosine (IVA). However; it causes significant decrease in systemic arterial blood pressure. The purpose of this study was to compare FFR response and systemic hemodynamic effects of low dose (50μg) with high dose (100μg) of IC-NTP.

Methods: We prospectively studied 36 coronary stenosis in 18 patients. FFR, Blood Pressure (BP) and Heart Rate (HR) were measured after intracoronary boluses of 50 and 100mcg of NTP and IVA (140μg/kg/min). IC-NTP boluses were given over <3 seconds. IVA was infused for 150 seconds. Repeated FFR measurements were performed only after resting coronary gradient (Pd/Pa) ratio, BP and HR returned to baseline.

Results: There was no significant difference in FFR values obtained after 50μg IC NTP, 100μg IC NTP and IVA (0.805±0.115, 0.804±0.113, 0.807±0.100, respectively, F=1.2, p=0.32). Correlation of FFR values obtained after lower and higher dose of NTP was excellent (r= 0.97, p<0.001). Decrease in blood pressure was significantly lower after 50μg IC NTP as compared to 100μg of IC NTP (systolic BP: 4.2% vs. 12%, t=4.3, p<0.001, diastolic BP: 3.6% vs. 7%, t=2.1, p=0.04, mean BP: 2% vs. 8%, t=3.7, p<0.001). No patients reported any side effects after IC NTP.

Conclusion: Intracoronary bolus of 50mcg IC-NTP results in similar coronary hyperemia as 100mcg and or IVA. Lower dose of IC NTP results in significantly less systemic hypotension and should be preferred dose in subjects with contraindications to adenosine or borderline blood pressure.

Keywords: Adenosine; Coronary artery disease; Fractional flow reserve; Hyperemia; Sodium nitroprusside

Summary

Intracoronary sodium nitroprusside at a dose of 50 micrograms evokes FFR response comparable to FFR induced by 100 micrograms of sodium nitroprusside and intravenous infusion of adenosine (140μg/kg/min for 150 seconds). As opposed to intravenous adenosine and 100μg of sodium nitroprusside, intracoronary sodium nitroprusside at a dose of 50μg has minimal effects on systemic blood pressure.

Introduction

Fractional Flow Reserve (FFR) measurement is now routinely used to assess hemodynamic significance of intermediate coronary artery stenosis and guide percutaneous coronary intervention [1,2]. Its diagnostic accuracy heavily relies on the ability to achieve maximal coronary hyperemia, as submaximal coronary vasodilation leads to underestimation of the functional severity of stenosis [3- 5]. Intravenous adenosine is currently the most commonly used pharmacologic agent for FFR study [6,7]. However, it is expensive, requires cumbersome and time demanding setup and not well tolerated or contraindicated in patients with reactive airway disease, advanced cardiac conduction disorders or concomitant therapy with dipyridamole [8-10]. Intracoronary adenosine has a lower rate of systemic effects than intravenous infusion, but it appears that previously recommended doses do not evoke maximal coronary hyperemia and currently there is no agreement which dose should be used as a “standard” [11-13]. Sodium nitroprusside (NTP) appears to be a very reliable, convenient and inexpensive alternative to adenosine [14-17]. We have shown that intracoronary bolus of NTP at a dose of 100μg has better sensitivity than intravenous adenosine (140μg/kg/min) and is better tolerated by patients [14]. However, intracoronary bolus of NTP at the dose of 100μg, leads to transient, although significant decrease in systemic blood pressure, which can be potentially harmful in patients with severe LV dysfunction or low systemic blood pressure. The aim of this study was to assess whether lower dose of intracoronary NTP will have less systemic hemodynamic effect and at the same time retains maximal coronary vasodilatory effects. We compared FFR response and effects on systemic blood pressure of 100μg and 50μg NTP given as an intracoronary bolus.

Materials and Methods

Study population

We routinely use both IV adenosine and IC NTP (100mcg bolus) to assess FFR response as De Luca et. al. demonstrated lack of full hyperemia with a high percentage of subjects treated with IV adenosine. If FFR values obtained with IC NTP and IV adenosine are discrepant we consider the lower value to make a decision regarding coronary intervention. We used the lower value when discrepant results were obtained as it has previously been shown that patients can be non-responders to adenosine, and have also been noted to not achieve maximal hyperemia despite higher doses of nitroprusside or adenosine. We studied 36 coronary artery stenotic lesions in 18 consecutive patients who underwent clinically indicated FFR at the University Hospital between July 2012 and October 2012. The study was approved by the University Hospital Institutional Review Board.

Coronary angiography

A standard percutaneous femoral approach was used to obtain arterial access. Diagnostic coronary angiography was performed by the Judkins technique with 6-F right and left coronary catheters. The electrocardiogram, arterial blood pressure and arterial oxygen saturation were continuously monitored throughout the procedure. Decision to perform FFR measurements was based on visual assessment of the stenotic lesion.

Pressure measurements

After administration of intravenous heparin (60U/kg), a guiding catheter was inserted. Guiding catheters without side holes were used. Intracoronary nitroglycerine 150μg bolus was injected via the guiding catheter. A 0.014-inch high-fidelity pressure-recording guide wire (Prime Wire, Volcano, San Diego, California) was externally calibrated (zeroed) and then the wire was advanced to the tip of the guiding catheter. It was verified that the measured pressures in the pressure wire and the guiding catheter were equal (normalization). Subsequently, the pressure wire was advanced into the coronary artery with the pressure sensor placed distal to the target lesion site. Distal coronary and aortic pressures were measured at baseline and at maximal hyperemia. Pressure signals were continuously recorded at a baseline speed of 25mm/s, and a beat-to-beat analysis of mean pressure was performed. Once stable pressure signal was obtained, measurements were recorded. FFR was calculated as a ratio of intracoronary pressure (Pd) to aortic pressure (Pa) obtained during maximal hyperemia. FFR < 0.8 was considered hemodynamically significant [2].

Pharmacological protocol

Once pressure wire sensor was positioned distal to the interrogated lesion, NTP at a dose of 50μg (0.5mL of 20mg in 250mL D5W) was injected over 3 seconds via the guiding catheter. After injection Pd/ Pa ratio, blood pressure and heart rate were monitored until all parameters returned to baseline levels. Subsequently bolus of IC NTP at the dose of 100μg (1mL of 20mg in 250mL D5W) was given. The time to reach maximal hyperemia and the duration of steadystate maximal hyperemia after each NTP injection was recorded. After Pd/ Pa ratio, blood pressure and heart rate returned to baseline level, a peripheral IV infusion of adenosine at a dose of 140μg/kg/ min was administered through a major arm vein with the use of ratecontrolled infusion pump. Infusion was continued for a minimum of 150 seconds and FFR was measured when steady-state hyperemia was achieved. Nitroprusside was given first as to avoid the potential incremental effects of adenosine before the use of nitroprusside.

Statistical analysis

All analyses were performed using STATISTICA® for Windows version 8 (Stat Soft Inc., Tulsa, Oklahoma). Normality of distribution of continuous variables was checked with Kolmogorov-Smirnov test. Data are presented as mean ± SD. Continuous variables were compared using paired t-test. Multiple comparisons were performed with repeated measures ANOVA. If statistical significance was found, post hoc Bonferroni test was used. Correlations were calculated using Pearson’s correlation coefficient. A p value of < 0.05 was considered significant. A formal power calculation was not performed at the time of the study initiation as the investigation is a pilot study by design.

Results

Baseline characteristics: We consecutively studied 18 patients (15 males and 3 females) of mean age 63±6 years and weight of 86±21kg. Mean baseline heart rate (HR) was 72±11 beats/min. Systolic, diastolic and mean arterial pressures were: 144±30, 78±12 and 101±15 mmHg, respectively. All patients were in sinus rhythm at the beginning of the procedure. Indications for coronary angiography were: positive stress test in 9 patients, unstable angina in 4 patients and Non ST-Elevation Myocardial Infarction (NSTEMI) in 4 patients. Baseline angiographic characteristics are reported in Table 1.